Caffeine exposure from beverages and its association with self-reported sleep duration and quality in a large sample of Icelandic adolescents.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 18 05 2021
revised: 16 08 2021
accepted: 07 09 2021
pubmed: 13 9 2021
medline: 10 2 2022
entrez: 12 9 2021
Statut: ppublish

Résumé

Previous risk assessments have concluded that adolescent's caffeine exposure from energy drinks (ED) are of limited concern. Recent surveys have, however, shown substantial increase in consumption. This cross-sectional survey conducted in 2020 estimated caffeine exposure from beverages among ∼80% of all 13-15-year-old adolescents (n = 10358) relative to the European Food Safety Authority's level of no safety concern of (3.0 mg/kg bw) and level for effects on sleep (1.4 mg/kg bw). Associations with self-reported sleep duration and quality were also explored. ED consumers were more likely to exceed the limit of no safety concern (prevelance: 12-14%) compared to non-ED-consumers (1-2%). Exceeding the limit for effects on sleep was also higher among ED consumers (31-38%) than non-ED-consumers (5-8%). Across categories of low (<0.5 mg/kg bw) to high (>3.0 mg/kg bw) caffeine intake, the prevalence of participants sleeping <6 h increased from 3% to 24%, respectively. The corresponding adjusted Prevalence Ratio was 4.5 (95% CI: 3.6, 5.7) and mean decrease in duration of sleep was 0.74 h (95% CI: 0.65, 0.84). In conclusion, caffeine intake from beverages above the limit of no safety concern was largely confined to ED consumers. Consistent with effects from intervention studies in adults, caffeine intake was strongly associated with self-reported sleep duration in this representative population.

Identifiants

pubmed: 34509583
pii: S0278-6915(21)00582-2
doi: 10.1016/j.fct.2021.112549
pii:
doi:

Substances chimiques

Caffeine 3G6A5W338E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112549

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

T I Halldorsson (TI)

Faculty of Food Science and Nutrition, School of Health Sciences University of Iceland, 102, Reykjavik Iceland; Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, 2300, Copenhagen, Denmark. Electronic address: tih@hi.is.

A L Kristjansson (AL)

Department of Social and Behavioral Sciences, School of Public Health, West Virginia University, Morgantown, WV, USA; Department of Psychology, Reykjavik University and Icelandic Center for Social Research and Analysis, Reykjavik, Iceland.

I Thorisdottir (I)

Department of Psychology, Reykjavik University and Icelandic Center for Social Research and Analysis, Reykjavik, Iceland.

C Oddsdóttir (C)

Keldur, Institute for Experimental Pathology, University of Iceland, Reykjavik, Iceland.

J Sveinbjörnsson (J)

Agricultural University of Iceland, Faculty of Agricultural Sciences, Hvanneyri, Iceland.

R Benediktsson (R)

Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, 101, Reykjavik, Iceland; Department of Endocrinology & Metabolism, Landspitali, The National University Hospital of Iceland, Eiriksgata 5, 101, Reykjavik, Iceland.

I D Sigfusdottir (ID)

Department of Psychology, Reykjavik University and Icelandic Center for Social Research and Analysis, Reykjavik, Iceland.

H Jörundsdóttir (H)

Matis Ltd., Vinlandsleid 12, 113, Reykjavik, Iceland.

Gunnlaugsdottir H (G)

Faculty of Food Science and Nutrition, School of Health Sciences University of Iceland, 102, Reykjavik Iceland; Matis Ltd., Vinlandsleid 12, 113, Reykjavik, Iceland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH